在非肥胖和肥胖个体中,酒精饮用模式和多重代谢综合征组件之间的关联
Ayako Kikuchi1,2, Hisashi Yoshimoto2,3, Takafumi Monma4
1Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba-shi, Japan.
Neuropsychopharmacology reports
|March 16, 2026
概括
不肥胖的人面临更高的代谢综合征组件风险,即使饮酒量适度. 减少饮酒对于非肥胖个体来说至关重要,以减轻这些健康风险.
科学领域:
- 代谢综合征研究研究
- 酒精消费研究 酒精消费研究
- 肥胖与健康 肥胖与健康
背景情况:
- 代谢综合征 (MetS) 是一组增加心脏病,中风和糖尿病风险的疾病.
- 酒精消费模式差异很大,它们对MetS组件的影响在肥胖和非肥胖个体之间有所不同.
研究的目的:
- 为了检查酒精饮用模式和多个MetS组件的存在之间的联系.
- 为了比较非肥胖人群与肥胖人群中的这些关联.
主要方法:
- 对36006名日本人 (40-64岁) 的横截面分析.
- 数据包括医疗检查,问卷和保险索赔.
- 修改Poisson回归分析了与饮酒模式相关的MetS组件,并对共变量进行调整.
主要成果:
- 在非肥胖 (每天≥20g/day,有时≥40g/day) 和肥胖 (每天≥60g/day) 个体中,针对多个MetS组件确定了高风险的饮酒模式.
- 与肥胖个体相比,非肥胖个体在风险饮酒模式中显示出MetS组件的更高的流行率.
- 低风险饮酒模式 (非肥胖者每天少于20克;有时或每天少于20克或肥胖者每天少于20克) 与降低MetS风险有关.
结论:
- 与肥胖个体相比,非肥胖个体的风险更大,即使饮酒量较低,也会产生多个MetS组件.
- 减少酒精消费的有针对性的干预措施对非肥胖人口尤为重要.
- 了解这些差异性风险可以为个性化的公共卫生策略提供信息.
相关概念视频
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
267
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
267
Overview of Carbohydrate Metabolism
4.2K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
4.2K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
351
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
351
Stress Prevention and Stress Management Techniques IV
308
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
308
Overview of Lipid Metabolism
6.5K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.5K


